4.6 Review

A Narrative Review on CD44's Role in Glioblastoma Invasion, Proliferation, and Tumor Recurrence

Related references

Note: Only part of the references are listed.
Article Oncology

Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics

Jing Zhang et al.

Summary: Epithelial-mesenchymal transition (EMT) is involved in various aspects of tumor development. The tumor microenvironment, consisting of different stroma cells and biochemical factors, influences the EMT program and tumor progression. This review explores the effects of tumor microenvironmental signals on EMT regulation, discusses the molecular mechanisms of EMT in therapy resistance, and proposes new therapeutic approaches targeting the tumor microenvironment to impact EMT and tumor progression.

SEMINARS IN CANCER BIOLOGY (2023)

Article Biochemistry & Molecular Biology

Identification of CD44 as a Reliable Biomarker for Glioblastoma Invasion: Based on Magnetic Resonance Imaging and Spectroscopic Analysis of 5-Aminolevulinic Acid Fluorescence

Akihiro Inoue et al.

Summary: This study analyzed the relationship between CD44 expression and magnetic resonance imaging (MRI)-based invasiveness of recurrent glioblastoma multiforme (GBM). High-invasive GBM showed significantly higher CD44 expression and was associated with worse survival. In addition, the study investigated the relationship between 5-aminolevulinic acid (5-ALA) spectroscopy-based tumor invasiveness and CD44 expression.

BIOMEDICINES (2023)

Review Biochemistry & Molecular Biology

The state of CD44 activation in cancer progression and therapeutic targeting

Qian Guo et al.

Summary: CD44, a non-kinase transmembrane glycoprotein, interacts with its major ligand hyaluronan to trigger downstream signaling cascades that promote cellular behaviors such as proliferation and invasiveness. The activation state of CD44 varies in different tissues, but its role in tumor progression and CSC properties requires further investigation.

FEBS JOURNAL (2022)

Editorial Material Biochemistry & Molecular Biology

Epithelial-Mesenchymal Transition (EMT) 2021

Guidalberto Manfioletti et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Oncology

CD44 Depletion in Glioblastoma Cells Suppresses Growth and Stemness and Induces Senescence

Constantinos Kolliopoulos et al.

Summary: CD44 plays an important role in the progression of glioblastoma multiforme (GBM) by influencing cell growth, stemness, senescence, and interaction with the hyaluronan-enriched microenvironment.

CANCERS (2022)

Article Medicine, Research & Experimental

MiR-373/miR-520s-CD44 Axis Significantly Inhibits the Growth and Invasion of Human Glioblastoma Cells

Shuo Feng et al.

Summary: This study investigated the role of miR-373 and miR-520s in glioblastoma by targeting CD44 expression, affecting the growth and invasiveness of GBM cells. The expression levels of these miRNAs and CD44 could potentially serve as valuable biomarkers for GBM prognosis.

ARCHIVES OF MEDICAL RESEARCH (2022)

Article Cell Biology

Distinct contributions of partial and full EMT to breast cancer malignancy

Fabiana Lueoend et al.

Summary: EMT is a transient and reversible process where cancer cells transition between epithelial and mesenchymal states. Partial EMT cells contribute to metastasis and chemoresistance, while full EMT cells fail to colonize the lungs but are enriched in recurrent tumors post-chemotherapy.

DEVELOPMENTAL CELL (2021)

Article Oncology

CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma

Masahiro Nishikawa et al.

Summary: This study focused on the expression and functions of CD44 and VEGF in bevacizumab therapy. It found that GBMs expressing high P/C ratio of CD44 were more refractory to Bev and had shorter survival time. CD44 may reduce the antitumor effect of Bev and could be a useful biomarker predicting responsiveness to Bev in GBM.

CANCER MEDICINE (2021)

Article Multidisciplinary Sciences

MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44

Margaret Yeh et al.

Summary: This study revealed that miR-138 can inhibit glioblastoma cell proliferation and improve survival rates in mice through direct downregulation of CD44 expression.

SCIENTIFIC REPORTS (2021)

Article Oncology

Hypoxia-induced phenotypic transition from highly invasive to less invasive tumors in glioma stem-like cells: Significance of CD44 and osteopontin as therapeutic targets in glioblastoma

Masahiro Nishikawa et al.

Summary: The poor prognosis of glioblastoma multiforme (GBM) is mainly attributed to highly invasive glioma stem-like cells (GSCs) in tumors. Differential regulation by hypoxia levels influences the behavior of GSCs, demonstrating the key role of interaction between CD44 and osteopontin in tumor progression in GBM.

TRANSLATIONAL ONCOLOGY (2021)

Review Neurosciences

Mechanisms of Invasion in Glioblastoma: Extracellular Matrix, Ca2+ Signaling, and Glutamate

Jae-Seon So et al.

Summary: Glioblastoma is a highly malignant form of primary brain tumor with very low complete resection rate, as the GBM cells interact with various brain cells and modify the extracellular matrix to facilitate invasion. Ca2+ signaling and glutamate release play key roles in GBM cell migration and gene expression. Therapeutic interventions targeting these mechanisms may help inhibit GBM invasion.

FRONTIERS IN CELLULAR NEUROSCIENCE (2021)

Review Pharmacology & Pharmacy

Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics

Gul-e-Saba Chaudhry et al.

Summary: Cancer progression involves the pivotal roles of HA and CD44, their interaction regulating survival signaling pathways affecting cell proliferation and metastasis. Targeting HA, CD44, and their binding may offer promising strategies for cancer therapeutics.

ADVANCED PHARMACEUTICAL BULLETIN (2021)

Review Medicine, Research & Experimental

Glioma stem cells and their roles within the hypoxic tumor microenvironment

Nathaniel H. Boyd et al.

Summary: Tumor microenvironments result from cellular alterations in cancer that promote unrestricted growth and angiogenesis, with hypoxia and acidic stress known to modulate therapeutic resistance. Understanding the interplay between tumor microenvironments and glioma stem cells is crucial for developing better treatment options for glioblastoma.

THERANOSTICS (2021)

Review Biochemistry & Molecular Biology

Integrin Signaling in Glioma Pathogenesis: From Biology to Therapy

Aleksandra Ellert-Miklaszewska et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Oncology

High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas

Daolin Si et al.

CANCER MANAGEMENT AND RESEARCH (2020)

Article Multidisciplinary Sciences

A mode of cell adhesion and migration facilitated by CD44-dependent microtentacles

Kayla J. Wolf et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Oncology

Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond

Shing Yau Tam et al.

FRONTIERS IN ONCOLOGY (2020)

Article Biochemistry & Molecular Biology

Adaptive Changes of Glioblastoma Cells Following Exposure to Hypoxic (1% Oxygen) Tumour Microenvironment

Ahmed Musah-Eroje et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Medicine, Research & Experimental

Evaluating the Efficiency of Hyaluronic Acid for Tumor Targeting via CD44

Alice Spadea et al.

MOLECULAR PHARMACEUTICS (2019)

Article Cell Biology

Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells

Linda T. Senbanjo et al.

CELL COMMUNICATION AND SIGNALING (2019)

Review Biochemistry & Molecular Biology

Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma

Monica Fedele et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Oncology

Glioblastoma: Microenvironment and Niche Concept

Davide Schiffer et al.

CANCERS (2019)

Article Oncology

Prognostic Value of Cyclin D1 and CD44 Expression in Gastric Adenocarcinoma

Hanaa M. Ibrahim et al.

JOURNAL OF GASTROINTESTINAL CANCER (2019)

Article Anatomy & Morphology

CD44 Immunoexpression is Unfavorable Predictor in Ovarian Serous Cancer

Dragana Karan Krizanac et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2018)

Review Neurosciences

Glioma infiltration and extracellular matrix: key players and modulators

Valeria Pereira Ferrer et al.

Article Dentistry, Oral Surgery & Medicine

Prognostic significance of elevated serum CD44 levels in patients with oral squamous cell carcinoma

Sharada Sawant et al.

JOURNAL OF ORAL PATHOLOGY & MEDICINE (2018)

Article Biotechnology & Applied Microbiology

CD44 overexpression related to lymph node metastasis and poor prognosis of pancreatic cancer

Yijuan Liu et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2018)

Article Medicine, Research & Experimental

CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism

Ruifang Gao et al.

THERANOSTICS (2018)

Article Multidisciplinary Sciences

FMISO-PET-derived brain oxygen tension maps: application to glioblastoma and less aggressive gliomas

Ararat Chakhoyan et al.

SCIENTIFIC REPORTS (2017)

Article Biotechnology & Applied Microbiology

Prognostic significance of CD24 and CD44 in breast cancer: a meta-analysis

Zhu Wang et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2017)

Review Biochemistry & Molecular Biology

EMT: 2016

M. Angela Nieto et al.

Review Clinical Neurology

The role of CD44 in glioblastoma multiforme

Kelly L. Mooney et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2016)

Review Pharmacology & Pharmacy

Pharmacology of the cell/matrix form of adhesion

Jacopo Meldolesi

PHARMACOLOGICAL RESEARCH (2016)

Review Cell & Tissue Engineering

Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets

Elena Codrici et al.

STEM CELLS INTERNATIONAL (2016)

Review Biochemistry & Molecular Biology

Matrix Hyaluronan Promotes Specific MicroRNA Upregulation Leading to Drug Resistance and Tumor Progression

Lilly Y. W. Bourguignon

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Review Oncology

Molecular heterogeneity in glioblastoma: potential clinical implications

Nicole Renee Parker et al.

FRONTIERS IN ONCOLOGY (2015)

Article Oncology

Prognostic significance of CD44 variant 2 upregulation in colorectal cancer

M. Ozawa et al.

BRITISH JOURNAL OF CANCER (2014)

Review Cell Biology

Regulation of alternative splicing of CD44 in cancer

Lubomir Prochazka et al.

CELLULAR SIGNALLING (2014)

Review Biochemistry & Molecular Biology

Brain tumor stem cells: Molecular characteristics and their impact on therapy

David L. Schonberg et al.

MOLECULAR ASPECTS OF MEDICINE (2014)

Article Multidisciplinary Sciences

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

Anoop P. Patel et al.

SCIENCE (2014)

Editorial Material Oncology

Glioblastoma Resistance to Anti-VEGF Therapy: Has the Challenge Been MET?

Joseph H. McCarty

CLINICAL CANCER RESEARCH (2013)

Article Multidisciplinary Sciences

A restricted cell population propagates glioblastoma growth after chemotherapy

Jian Chen et al.

NATURE (2012)

Article Biology

'Go or Grow': the key to the emergence of invasion in tumour progression?

H. Hatzikirou et al.

MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA (2012)

Article Multidisciplinary Sciences

Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell

Toshifumi Yae et al.

NATURE COMMUNICATIONS (2012)

Article Biochemistry & Molecular Biology

Elevated invasive potential of glioblastoma stem cells

Lin Cheng et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)

Review Clinical Neurology

Glioblastoma, Cancer Stem Cells and Hypoxia

Eli E. Bar

BRAIN PATHOLOGY (2011)

Review Oncology

Angiogenesis and invasion in glioma

Manabu Onishi et al.

BRAIN TUMOR PATHOLOGY (2011)

Article Clinical Neurology

Glioblastoma: Patterns of Recurrence and Efficacy of Salvage Treatments

Jiwon Oh et al.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2011)

Review Gastroenterology & Hepatology

The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer

Byung Ik Jang et al.

GUT AND LIVER (2011)

Article Medicine, Research & Experimental

CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression

Rhonda L. Brown et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Biochemistry & Molecular Biology

Oct4 regulates the miR-302 cluster in P19 mouse embryonic carcinoma cells

Haiying Liu et al.

MOLECULAR BIOLOGY REPORTS (2011)

Article Biochemistry & Molecular Biology

Regulation of somatic cell reprogramming through inducible mir-302 expression

Shi-Lung Lin et al.

NUCLEIC ACIDS RESEARCH (2011)

Article Multidisciplinary Sciences

Direct In Vivo Evidence for Tumor Propagation by Glioblastoma Cancer Stem Cells

Justin D. Lathia et al.

PLOS ONE (2011)

Article Otorhinolaryngology

SINGLE-MARKER IDENTIFICATION OF HEAD AND NECK SQUAMOUS CELL CARCINOMA CANCER STEM CELLS WITH ALDEHYDE DEHYDROGENASE

Matthew R. Clay et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2010)

Review Biochemistry & Molecular Biology

Hypoxia-Inducible Factors and the Response to Hypoxic Stress

Amar J. Majmundar et al.

MOLECULAR CELL (2010)

Article Biotechnology & Applied Microbiology

Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model

Li Ma et al.

NATURE BIOTECHNOLOGY (2010)

Article Biochemistry & Molecular Biology

Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer

Yu-Chih Chen et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)

Article Biochemistry & Molecular Biology

The epithelial-mesenchymal transition generates cells with properties of stem cells

Sendurai A. Mani et al.

Article Pharmacology & Pharmacy

Hyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistance

Bryan P. Toole et al.

DRUG RESISTANCE UPDATES (2008)

Article Biochemistry & Molecular Biology

miR-21 gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism

Shuji Fujita et al.

JOURNAL OF MOLECULAR BIOLOGY (2008)

Article Biochemistry & Molecular Biology

MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators

Galina Gabriely et al.

MOLECULAR AND CELLULAR BIOLOGY (2008)

Article Biochemistry & Molecular Biology

Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state

Shi-Lung Lin et al.

Article Multidisciplinary Sciences

Tumour invasion and metastasis initiated by microRNA 10b in breast cancer

Li Ma et al.

NATURE (2007)

Review Cell Biology

Hypoxia inducible factor-2α in cancer

Tobias Lofstedt et al.

CELL CYCLE (2007)

Article Cell Biology

Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-Actin

Veronique Orian-Rousseau et al.

MOLECULAR BIOLOGY OF THE CELL (2007)

Review Biochemistry & Molecular Biology

MicroRNAs: Genomics, biogenesis, mechanism, and function

DP Bartel

Review Oncology

Mechanism and biological significance of CD44 cleavage

O Nagano et al.

CANCER SCIENCE (2004)

Review Multidisciplinary Sciences

Cell migration: Integrating signals from front to back

AJ Ridley et al.

SCIENCE (2003)

Review Oncology

Cost of migration: Invasion of malignant gliomas and implications for treatment

A Giese et al.

JOURNAL OF CLINICAL ONCOLOGY (2003)

Article Biochemistry & Molecular Biology

Presenilin-dependent γ-secretase activity mediates the intramembranous cleavage of CD44

D Murakami et al.

ONCOGENE (2003)

Review Cell Biology

CD44: From adhesion molecules to signalling regulators

H Ponta et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)

Article Biochemistry & Molecular Biology

Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor β receptor I in metastatic breast tumor cells

LYW Bourguignon et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Review Biochemistry & Molecular Biology

Signaling properties of hyaluronan receptors

EA Turley et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)